Deep learning-based molecular morphometrics for kidney biopsies.

Journal: JCI insight
PMID:

Abstract

Morphologic examination of tissue biopsies is essential for histopathological diagnosis. However, accurate and scalable cellular quantification in human samples remains challenging. Here, we present a deep learning-based approach for antigen-specific cellular morphometrics in human kidney biopsies, which combines indirect immunofluorescence imaging with U-Net-based architectures for image-to-image translation and dual segmentation tasks, achieving human-level accuracy. In the kidney, podocyte loss represents a hallmark of glomerular injury and can be estimated in diagnostic biopsies. Thus, we profiled over 27,000 podocytes from 110 human samples, including patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN), an immune-mediated disease with aggressive glomerular damage and irreversible loss of kidney function. We identified previously unknown morphometric signatures of podocyte depletion in patients with ANCA-GN, which allowed patient classification and, in combination with routine clinical tools, showed potential for risk stratification. Our approach enables robust and scalable molecular morphometric analysis of human tissues, yielding deeper biological insights into the human kidney pathophysiology.

Authors

  • Marina Zimmermann
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Martin Klaus
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Milagros N Wong
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Ann-Katrin Thebille
    Institute of Medical Systems Biology, Center for Biomedical AI (bAIome), Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lukas Gernhold
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Christoph Kuppe
    Department of Nephrology and Clinical Immunology and.
  • Maurice Halder
    Department of Nephrology and Clinical Immunology and.
  • Jennifer Kranz
    St.-Antonius Hospital Eschweiler, Department of Urology, Eschweiler, Germany.
  • Nicola Wanner
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fabian Braun
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sonia Wulf
    Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Thorsten Wiech
    Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ulf Panzer
    III. Department of Medicine, Division of Translational Immunology, and.
  • Christian F Krebs
    III. Department of Medicine, Division of Translational Immunology, and.
  • Elion Hoxha
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Rafael Kramann
    Department of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
  • Tobias B Huber
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Stefan Bonn
    Institute of Medical Systems Biology, Center for Biomedical AI (bAIome), Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Victor G Puelles
    III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Department of Nephrology, Monash Health, and Center for Inflammatory Diseases, Monash University, Melbourne VIC 3168, Australia.